1. |
宋兴勃, 彭武, 王旻晋, 等. 361 例疑似肺孢子菌肺炎患者核酸检测结果分析. 国际检验医学杂志, 2018, 39(18): 2242-2245.
|
2. |
Catherinot E, Lanternier F, Bougnoux ME, et al. Pneumocystis jirovecii pneumonia. Infect Dis Clin North Am, 2010, 24(1): 107-138.
|
3. |
Maschmeyer G, Helweg-Larsen J, Pagano L, et al. ECIL guidelines for treatment of pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother, 2016, 71(9): 2405-2413.
|
4. |
Liu Y, Su L, Jiang SJ, et al. Risk factors for mortality from Pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis. Oncotarget, 2017, 8(35): 59729-59739.
|
5. |
Salzer HJF, Schäfer G, Hoenigl M, et al. Clinical, diagnostic, and treatment disparities between HIV-infected and Non-HIV-infected immunocompromised patients with pneumocystis jirovecii pneumonia. Respiration, 2018, 96(1): 52-65.
|
6. |
Sarkar S, Dubé MP, Jones BE, et al. Pneumocystis carinii pneumonia masquerading as tuberculosis. Arch Intern Med, 1997, 157(3): 351-355.
|
7. |
李昱霖, 梁志欣, 骆海伦, 等. 77 例肾移植术后患者并发肺部感染的临床分析. 解放军医学院学报, 2014, 35(6): 538-540.
|
8. |
Miller RF, Le Noury J, Corbett EL, et al. Pneumocystis carinii infection: current treatment and prevention. J Antimicrob Chemother, 1996, 37(Suppl B): 33-53.
|
9. |
Kaminski H, Belliere J, Burguet L, et al. Identification of predictive markers and outcomes of late-onset pneumocystis jirovecii pneumonia in kidney transplant recipients. Clin Infect Dis, 2020: ciaa1611.
|
10. |
Kim JE, Han A, Lee H, et al. Impact of pneumocystis jirovecii pneumonia on kidney transplant outcome. BMC Nephrol, 2019, 20(1): 212.
|
11. |
de Boer MG, de Fijter JW, Kroon FP. Outbreaks and clustering of pneumocystis pneumonia in kidney transplant recipients: a systematic review. Med Mycol, 2011, 49(7): 673-680.
|
12. |
Radisic M, Lattes R, Chapman JF, et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis, 2003, 5(2): 84-93.
|
13. |
Mulpuru S, Knoll G, Weir C, et al. Pneumocystis pneumonia outbreak among renal transplant recipients at a North American transplant center: risk factors and implications for infection control. Am J Infect Control, 2016, 44(4): 425-431.
|
14. |
Pan J, Fu Y, Cao Y, et al. Single-center retrospective analysis of prophylaxis and treatment of Pneumocystis carinii pneumonia in patients with renal dysfunction after renal transplantation. Ann Transplant, 2020, 25: e925126.
|
15. |
王明明, 杨学敏. 肾移植术后患者肺孢子菌肺炎临床特征分析. 临床肺科杂志, 2020, 25(9): 1355-1358.
|
16. |
刘永光, 郭颖, 李民, 等. 肾移植后并发卡氏肺孢子虫肺炎 36 例资料回顾. 中国组织工程研究与临床康复, 2010, 14(53): 10063-10066.
|
17. |
Lin D, Li WK, Rieder MJ. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole. Cochrane Database Syst Rev, 2007(2): CD005646.
|
18. |
Green H, Paul M, Vidal L, et al. Prophylaxis of pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and metaanalysis of randomized controlled trials. Mayo Clin Proc, 2007, 82(9): 1052-1059.
|
19. |
Martin SI, Fishman JA, the AST Infectious Diseases Community of Practice. Pneumocystis pneumonia in solid organ transplant recipients. Am J Transplant, 2009(Suppl 4): S227-S233.
|
20. |
Chapman FA, Dickerson JE, Daly C, et al. Impact of increased duration of trimethoprim-sulfamethoxazole prophylaxis for pneumocystis pneumonia after renal transplant. Ann Transplant, 2019, 24: 625-630.
|
21. |
Prasad GVR, Beckley J, Mathur M, et al. Safety and efficacy of prophylaxis for pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation. BMC Infect Dis, 2019, 19(1): 311.
|
22. |
Le Gal S, Toubas D, Totet A, et al. Pneumocystis infection outbreaks in organ transplantation units in france: a nation-wide survey. Clin Infect Dis, 2020, 70(10): 2216-2220.
|
23. |
Yazaki H, Goto N, Uchida K, et al. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host. Transplantation, 2009, 88(3): 380-385.
|
24. |
Faure E, Lionet A, Kipnis E, et al. Risk factors for Pneumocystis pneumonia after the first 6 months following renal transplantation. Transpl Infect Dis, 2017, 19(5).
|
25. |
Lee SH, Huh KH, Joo DJ, et al. Risk factors for pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients. Sci Rep, 2017, 7(1): 1571.
|
26. |
Depypere M, Saegeman V, Lagrou K. Typing of pneumocystis jirovecii by multilocus sequencing: evidence of outbreak?. Eur J Clin Microbiol Infect Dis, 2016, 35(6): 911-916.
|
27. |
Ricci G, Santos DW, Kovacs JA, et al. Genetic diversity of pneumocystis jirovecii from a cluster of cases of pneumonia in renal transplant patients: cross-sectional study. Mycoses, 2018, 61(11): 845-852.
|
28. |
Rostved AA, Sassi M, Kurtzhals JA L, et al. Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of pneumocystis jirovecii. Transplantation, 2013, 96(9): 834-842.
|
29. |
邱成, 叶剑锋, 戴帅, 等. 肾移植受者肺孢子菌肺炎流行病学特点分析. 中国医学前沿杂志(电子版), 2020, 12(7): 138-141.
|
30. |
Christe A, Walti L, Charimo J, et al. Imaging patterns of Pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients-a multicentre study. Swiss Med Wkly, 2019, 149: w20130.
|
31. |
Chou CW, Chao HS, Lin FC, et al. Clinical usefulness of HRCT in assessing the severity of pneumocystis jirovecii pneumonia: a cross-sectional study. Medicine (Baltimore), 2015, 94: e768.
|
32. |
丘金铭, 吴仁华. 肺孢子菌肺炎的影像学表现. 新发传染病电子杂志, 2019, 4(4): 235-239.
|
33. |
李晶晶, 邹洋, 安亦君, 等. 1341 例疑似肺孢子菌肺炎非 HIV 阳性患者病原学诊断分析. 传染病信息, 2016, 29(5): 272-275.
|
34. |
叶宁, 朱明利, 李茜茜, 等. 肺孢子菌肺炎实验室诊断研究进展. 中国卫生检验杂志, 2017, 27(4): 604-605, 608.
|
35. |
马兴璇, 唐石伏, 阳建伶, 等. (1,3)-β-D-葡聚糖实验干扰因素的研究进展. 中国当代医药, 2020, 27(9): 21-23.
|
36. |
Kinnunen S, Karhapää P, Juutilainen A, et al. Secular trends in infection-related mortality after kidney transplantation. Clin J Am Soc Nephrol, 2018, 13(5): 755-762.
|
37. |
段智梅, 姜淑娟, 邵杨, 等. 肾移植患者术后肺部感染的临床特征分析. 中华医院感染学杂志, 2018, 28(20): 3107-3110.
|